Lumos Pharma Inc (NASDAQ:LUMO)
| 7.69 Delayed Data As of May 13 |  0.00 / 0.00%Today’s Change | 6.15 Today|||52-Week Range 12.05 | +10.97% Year-to-Date |
Latest LUMO News | Press Releases
No recent news for Lumos Pharma Inc.
Today’s Trading
| Previous close | 7.69 |
| Today’s open | 7.53 |
| Day’s range | 7.36 - 7.90 |
| Volume | 3,070 |
| Average volume (3 months) | 23,078 |
| Market cap | $56.2M |
Data as of 3:59pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | -291.92% |
| Earnings growth (this year) | -9.50% |
| Earnings growth (next 5 years) | +15.24% |
| Revenue growth (last year) | +36.90% |
| P/E ratio | NM |
| Price/Sales | 251.12 |
| Price/Book | 0.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DMACDiaMedica Therapeuti... | -0.05 | -2.05% |
| ACHVAchieve Life Science... | +0.15 | +2.26% |
| ---- | ||
| ---- |
Data as of 05/16/2022
Financials
| Next reporting date | August 18, 2022 |
| EPS forecast (this quarter) | -$0.99 |
| Annual revenue (last year) | $230.0K |
| Annual profit (last year) | -$30.4M |
| Net profit margin | -13,230.43% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
